(Q41127925)

27 September 2017

1 reference

title

Management of psychotic, treatment-resistant depression (English)

1 reference

27 September 2017

1 reference

Rothschild AJ

1

1 reference

27 September 2017

1 June 1996

1 reference

Psychiatric Clinics of North America

27 September 2017

1 reference

27 September 2017

19

1 reference

27 September 2017

237-252

1 reference

27 September 2017

2

1 reference

Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Response of psychotic depression subtypes to pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Efficacy of amoxapine in psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Relapse in delusional depression: a retrospective study of the course of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The treatment of depression: Electroconvulsive therapy ν antidepressants: A naturalistic evaluation of 1,495 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Electroconvulsive therapy: results in depressive illness from the Leicestershire trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Psychotic vs. nonpsychotic depression: comparison of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Mood congruent and incongruent psychotic depressions: are they the same?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Clozapine use in diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional and nondelusional unipolar depression: further evidence for distinct subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Affective Syndromes, Psychotic Features, and Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Affective syndromes, psychotic features, and prognosis. II. Mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The clinical and neuroendocrine features of psychotic depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Demographic, Historical, and Symptomatic Features of the Nonmanic Psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Clozapine in the treatment of psychotic refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Elevated plasma homovanillic acid in depressed females with melancholia and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional depressive in-patients, 1892 to 1982

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A consensus conference on psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Psychotic depression: a separate entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional depression. A distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Recurrent psychotic depression. Evidence of diagnostic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Depression, drugs, and delusions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Verapamil in major (psychotic) depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The validity of major depression with psychotic features based on a community study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Sulpiride in the treatment of delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Mood disorders in the psychoneurologic borderland: three cases of responsiveness to carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Five-year outcome for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Amitriptyline plasma levels and clinical response in primary depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A Controlled Comparison of Simulated and Real ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Type and content of delusions in unipolar psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Plasma catecholamine metabolites in subtypes of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A prospective study of the treatment of psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The Treatment of Psychotic Major Depressive Disorder with Drugs and Electroconvulsive Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Treatment of major depression with steroid suppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional unipolar depression: description and drug response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Lithium augmentation in psychotic depression refractory to combined drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional depression*Phenomenology, neuroendocrine function, and tricyclic antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Psychotic depression: a review and clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Psychotic (delusional) depression: a meta-analysis of physical treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Effect of Clozapine on Psychotic Depression and Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant--antipsychotic combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Imipramine response in deluded depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Depression, delusions, and suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Dexamethasone increases plasma free dopamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A corticosteroid/dopamine hypothesis for psychotic depression and related states

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

A case of monthly unipolar psychotic depression with suicide attempt by self-burning: selective response to bupropion treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

The pharmacological treatment of delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional versus non-delusional depression: Neurochemical differences

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Delusional depression and suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Ketoconazole administration in hypercortisolemic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

An atypical responder to clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970286-0

7 January 2021

10.1016/S0193-953X(05)70286-0

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8827188